Acadian Asset Management
PLSE icon

Acadian Asset Management’s Pulse Biosciences PLSE Stock Holding History

Acadian Asset Management’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,536
Closed -$26K – 2041
2024
Q3 		$26K Buy
+1,536
New +$26.2K ﹤0.01% 1939

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Acadian Asset Management's PLSE Position: Q4 2024 in Review

Acadian Asset Management sold out of Pulse Biosciences (PLSE) in Q4 2024, closing a stake of 1,536 shares — an estimated $26K sold.

Acadian Asset Management first reported a position in PLSE in Q3 2024 and held it in 1 quarter. The position peaked at $26K in Q3 2024. 73 funds tracked by Wall St. Rank hold PLSE as of Q4 2024.

  • Acadian Asset Management reported no remaining Pulse Biosciences position as of Q4 2024 after selling out during the quarter.
  • Acadian Asset Management sold 1,536 Pulse Biosciences shares in Q4 2024, an estimated $26K.
  • Acadian Asset Management first reported a position in Pulse Biosciences in Q3 2024 and held it in 1 quarter.
  • Acadian Asset Management's Pulse Biosciences position peaked at $26K in Q3 2024.
  • 73 funds tracked by Wall St. Rank held Pulse Biosciences as of Q4 2024.

Based on Acadian Asset Management's 13F filing for Q4 2024, filed 11 Feb 2025.